BCM
IDXX icon

Buckhead Capital Management’s Idexx Laboratories IDXX Stock Holding History

Buckhead Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Hold
742
– – 0.13% 113
2026
Q1 		$417K Buy
742
+75
+11% +$48.1K 0.16% 98
2025
Q4 		$451K Buy
667
+37
+6% +$25.2K 0.16% 100
2025
Q3 		$403K Buy
+630
New +$382K 0.15% 100

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Buckhead Capital Management's IDXX Position: Q2 2026 in Review

Buckhead Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 742 shares worth $391K. The position accounts for 0.13% of the portfolio, ranked #113.

Buckhead Capital Management first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $451K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Buckhead Capital Management held 742 shares of Idexx Laboratories worth $391K as of Q2 2026.
  • Buckhead Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.13% of Buckhead Capital Management's portfolio in Q2 2026, its #113 holding.
  • Buckhead Capital Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Buckhead Capital Management's Idexx Laboratories position peaked at $451K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Buckhead Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.